melanoma: considerations in checkpoint inhibition
Published 7 years ago • 199 plays • Length 7:44Download video MP4
Download video MP3
Similar videos
-
0:58
dr. tawbi on checkpoint inhibition in melanoma
-
8:15
single vs dual checkpoint inhibition in melanoma
-
1:58
dr. weber on duration of checkpoint inhibitor therapy in melanoma
-
8:43
future role of checkpoint inhibitors in melanoma
-
7:51
checkpoint inhibitors: combination therapy in melanoma
-
14:32
evaluating the use of immune checkpoint inhibitors in melanoma
-
1:05
dr. weber on the future of checkpoint inhibitors in melanoma
-
19:25
melanoma review for the absite - questions and answers
-
7:06
an overview of non-melanoma skin cancer epidemiology
-
6:33
sargramostim and icis: combinatorial therapeutic studies in metastatic melanoma – video abstract
-
7:11
checkpoint inhibitors in metastatic melanoma
-
0:58
the future of immune checkpoint inhibition in melanoma
-
4:00
earlier use of checkpoint inhibitors
-
8:49
sequencing of checkpoint agents in melanoma
-
1:27
analyzing the role of checkpoint inhibitors for the treatment of melanoma
-
1:06
evaluating the suitability of checkpoint inhibitors with biomarkers in patients with melanoma
-
4:58
expert report on neoadjuvant immune checkpoint inhibitors for melanoma
-
3:10
targeted therapy or checkpoint inhibitors in melanoma: which is better?
-
1:45
mechanisms of resistance to checkpoint inhibitors in melanoma
-
1:11
pd-1 checkpoint inhibition impacts treatment of melanoma and lung cancer
-
0:55
the activity of checkpoint inhibitors in melanoma
-
1:25
dr. edith perez on immune checkpoint inhibition in triple-negative breast cancer